Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40P16 | ISIN: SE0022419784 | Ticker-Symbol: 61L0
München
24.01.25
08:00 Uhr
21,740 Euro
0,000
0,00 %
1-Jahres-Chart
SECTRA AB Chart 1 Jahr
5-Tage-Chart
SECTRA AB 5-Tage-Chart
RealtimeGeldBriefZeit
21,32021,96024.01.
PR Newswire
350 Leser
Artikel bewerten:
(2)

University hospitals in the UK join Homerton Healthcare's public cloud service from Sectra--enhances collaboration for improved care

Finanznachrichten News

LINKÖPING, Sweden, Oct. 22, 2024 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) SaaS in the cloud, Sectra One Cloud, will be used by Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) in the UK as they join Homerton Healthcare's current cloud solution for medical imaging. By using one unified platform the current cooperation between the hospitals will be enhanced which is anticipated to improve workflow and production at lower cost. Moreover, it will relieve BHRUT's IT burden and costs for IT as Sectra takes full responsibility for the technology and operation of the system.

Since 2015, BHRUT has been using Sectra's radiology solution. Operating from King George Hospital in Ilford and Queen's Hospital in Romford, BHRUT serves the communities of Barking, Dagenham, Havering, and Redbridge in East London and Essex. As a part of the same hospital region as Homerton Healthcare-which adopted Sectra's cloud service in 2023-BHRUT collaborates continuously with Homerton.

"We cooperate extensively with Homerton to ensure the patients in our region receive timely care, and therefore see huge benefits of further facilitating that collaboration. By having a joint Sectra solution, our radiologists will have immediate access to each other's images and patient data, which will make it easier for us to collaborate around patient cases," says David Newey, Interim Chief Digital Transformation Officer at BHRUT.

Sectra will provide BHRUT with a fully managed cloud service and continuously monitor, optimize, and upgrade the solution, as well as provide 24/7 support to ensure a smooth experience over time. This will create a comprehensive system at BHRUT, designed to accommodate potential growth as volumes increase and as potential expansion into other specialties is explored.

"As Sectra takes responsibility for the operation and maintenance of the system, the resilience of the service we provide to our patients will improve, whilst our maintenance overhead will be reduced," Newey adds.

The contract for Sectra One Cloud was signed in the second quarter of Sectra's 2024/2025 fiscal year and BHRUT will initially use the modules for radiology and breast imaging.

"An increasing number of hospitals are transitioning to cloud-based solutions to enhance security and reduce IT burdens. This shift addresses the widespread challenge of shortages in IT staff required to manage hospital systems. Therefore, we are proud to provide BHRUT with a solution that relieves this significant burden. We are looking forward to continuing to support them and to enhance their cooperation with Homerton for improved patient care in the region," says Jane Rendall, managing director for Sectra UK and Ireland.

Sectra's enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra's website to read more about Sectra and why it's top-ranked in "Best in KLAS".

About Sectra

Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2023/2024 fiscal year totaled SEK 2,964 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website.

For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, 46 (0) 705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/sectra/r/university-hospitals-in-the-uk-join-homerton-healthcare-s-public-cloud-service-from-sectra-enhances-,c4053880

The following files are available for download:

https://news.cision.com/sectra/i/sectra-s-radiology-module,c3343951

Sectra's radiology module

Cision View original content:https://www.prnewswire.co.uk/news-releases/university-hospitals-in-the-uk-join-homerton-healthcares-public-cloud-service-from-sectraenhances-collaboration-for-improved-care-302282763.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.